The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats

European Journal of Pharmacology

Volumn 572, Issue 2-3, 2007, Pages 171-174

  Gyertyán, István ^a   Sághy, Katalin ^a  

^a GEDEON RICHTER LTD   (Hungary)

Author keywords

Dopamine D3 receptor antagonist; Haloperidol induced catalepsy; S 33084; SB 277011

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; HALOPERIDOL; N [4 (8 CYANO 1,3A,4,9B TETRAHYDRO 3H BENZOPYRANO[3,4 C]PYRROLE 2 YL)BUTYL](4 PHENYL)BENZAMIDE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; S 33084; UNCLASSIFIED DRUG; BENZOPYRAN DERIVATIVE; NITRILE; PYRROLE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; WISTAR RAT;

ANIMALS; BENZOPYRANS; CATALEPSY; HALOPERIDOL; MALE; NITRILES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D3; TETRAHYDROISOQUINOLINES;

EID: 34548771303     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.035     Document Type: Article

References (23)

1. Cohen B.M., Tsuneizumi T., Baldessarini R.J., Campbell A., and Babb S.M. Differences between antipsychotic drugs in persistence of brain levels and behavioral effects. Psychopharmacology (Berl) 108 (1992) 338-344
2. 3 receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. Mol. Pharmacol. 56 (1999) 1025-1030
3. 2 receptor expressing neurons. Neuropsychopharmacology 20 (1999) 60-80
4. 3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011. Behav. Pharmacol. 15 (2004) 253-262
5. 2 affinity results in favorable antipsychotic activity: behavioral data. Int. J. Neuropsychopharmacol. 5 (2002) S174
6. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Rev. 49 (2005) 77-105
7. 3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacol. Ther. 90 (2001) 231-259
8. 3 receptor antagonists as therapeutic agents. Drug Discov. Today 10 (2005) 917-925
9. 2 receptors. Implications for atypical antipsychotic action. J. Psychiatry Neurosci. 25 (2000) 161-166
10. 2 affinity results in favorable antipsychotic activity: neurochemical data. Int. J. Neuropsychopharmacol. 5 (2002) S174
11. 3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharmacology 179 (2005) 567-575
12. 2 receptors elicits prolactin secretion and catalepsy. J. Pharmacol. Exp. Ther. 275 (1995) 885-898
13. 3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats. Eur. J. Pharmacol. 321 (1997) R7-R9
14. 3 receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. J. Pharmacol. Exp. Ther. 293 (2000) 1048-1062
15. 3 receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. J. Pharmacol. Exp. Ther. 293 (2000) 1063-1073
16. 2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology (Berl) 174 (2004) 341-357
17. Millan M.J., Di Cara B., Dekeyne A., Panayi F., De Groote L., Sicard D., Cistarelli L., Billiras R., and Gobert A. Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. J. Neurochem. 100 (2007) 1047-1061
18. 3 receptor antagonist, SB-277011-A. J. Pharmacol. Exp. Ther. 294 (2000) 1154-1165
19. 3 receptor in schizophrenia and in antipsychotic drug actions. Brain Res. Rev. 31 (2000) 77-287
20. 3 receptors in learning and memory in the rat. Eur. J. Pharmacol. 336 (1997) 107-112
21. Silverdale M.A., Nicholson S.L., Ravenscroft P., Crossman A.R., Millan M.J., and Brotchie J.M. Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate. Exp. Neurol. 188 (2004) 128-138
22. 3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J. Pharmacol. Exp. Ther. 295 (2000) 1223-1231
23. 3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology 31 (2006) 1382-1392